We are very excited to announce that the Canadian Spondylitis Association has added a great tool for patients to their website. This tool was developed by our own clinical pharmacist, Carolyn Whiskin. The tool was designed to assist patients with rheumatic autoimmune diseases and better understand the risks of being in a state of active disease vs. receiving advanced therapies that can result in low disease activity or remission. It is important to understand that all treatments approved by Health Canada must demonstrate that the health benefits outweigh any risks. Even with that knowledge, patients need confidence that a treatment makes sense for them, and this tool will help in that process.
Click here to use the Arthritis Treatment Risks tool.
We would love to hear your feedback and hope this is a beneficial resource for you.
Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain, and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.
Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…
Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…
Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…
Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…
Every year on October 12, World Arthritis Day raises awareness about the millions of people…
Tremfya (guselkumab) has been available for several years to treat plaque psoriasis and psoriatic arthritis.…